Download PDF
Thromb Haemost 1996; 76(02): 278-279
DOI: 10.1055/s-0038-1650571
Letters to the Editor
Schattauer GmbH Stuttgart

Elevated Levels of Plasma Endothelin-1, von Willebrand Factor, and Urinary Albumin Excretion in Three Relatives with Pseudoxanthoma Elasticum

Alfonso Piccoli
The University of Rome “La Sapienza”, Chair of 1st Internal Medicine, Italy
,
Daniela Ricciardi
The University of Rome “La Sapienza”, Chair of 1st Internal Medicine, Italy
,
Anna Santucci
1   University of L’Aquila, Department of Internal Medicine and Public Health, Italy
,
Vincenzo Barnaba
The University of Rome “La Sapienza”, Chair of 1st Internal Medicine, Italy
,
Claudio Ferri
The University of Rome “La Sapienza”, Chair of 1st Internal Medicine, Italy
› Author Affiliations
Further Information

Publication History

Received 09 January 1996

Accepted after resubmission 15 April 1996

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Lebwohl M, Neldner K, Pope FM, Paepe A, Christiano AM, Boyd CD, Uitto J, Me Kusick VA. Classification of pseudoxanthoma elasticum: report of consensus conference. J Am Acad Dermatol 1994; 30 (01) 103-107
    CrossrefPubMedGoogle Scholar
  • 2 Lebwohl M, Halperin J, Phelps RG. Occult pseudoxanthoma elasticum in patients with premature cardiovascular disease. N Engl J Med 1993; 329: 1237-1239
    CrossrefPubMedGoogle Scholar
  • 3 Mendelsohn G, Bulkley BM, Hutchins GM. Cardiovascular manifestations of pseudoxanthoma elasticum. Arch Pathol Lab Med 1978; 102: 298-302
    PubMedGoogle Scholar
  • 4 Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett Jr JC. Circulating and tissue andothelin in advanced atherosclerosis. N Engl J Med 1991; 325: 997-1001
    CrossrefPubMedGoogle Scholar
  • 5 Stehouwer CDA, Nauta JIP, Zeldenrust GC, Hackeng WHL, Donker AJM. Den Ottolander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-323
    CrossrefPubMedGoogle Scholar
  • 6 Morise T, Takeuchi Y, Kawano M, Koni I, Takeda R. Increased plasma levels of immunoreactive endothelin and von Willebrand Factor in NIDDM patients. Diabetes Care 1995; 18: 87-89
    CrossrefPubMedGoogle Scholar
  • 7 Vermes I, Spooren PFMJ, Kalsbeek-Batenburg EM. In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia 1993; 36: 472-473
    CrossrefPubMedGoogle Scholar
  • 8 Daví G, Giannaresi C, Vignesi S, Di Francesco L, Ferri C, Ganci S, Man-sueto S. Demonstration of rickettsia conorii-induced coagulative and platelet activation in vivo in patient with mediterranean spotted fever. Thromb Haemost 1995; 74 (02) 631-634
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995; 80: 829-835
    PubMedGoogle Scholar
  • 10 Nichols M, Bellinger TDA, Tate DA, Reddick RL, Read MS, Koch G, Brinkhous KM, Griggs TR. von Willebrand Factor and occlusive arterial thrombosis: a study in normal and von Willebrand’s disease pigs with diet-induced hypercholesterolemia and atherosclerosis. Arteriosclerosis 1990; 10: 449-461
    CrossrefPubMedGoogle Scholar
  • 11 Ferri C, Properzi G, Santucci A. Endothelin-1: a pathogenic factor in human disease or a physiologist’s curiosity. High Blood Press 1995; 4: 1-19
    PubMedGoogle Scholar